Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2026-05-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 91% confidence The document is a detailed "대량보유상황보고서" (Large Shareholding Situation Report) under Korea’s Capital Markets Act, outlining the number of shares held, changes in shareholding, related parties, and reasons for the change (partial repayment of secured loan). This aligns with a Major Shareholding Notification (MRQ).
2026-05-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a mandatory filing detailing the share ownership status and transaction history of an officer/major shareholder for (주)바이넥스, including tables of share purchases, disposals, and ownership percentages. This matches an insider trading disclosure by a director/executive. Therefore it is classified as Director’s Dealing (DIRS).
2026-05-22 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제 42 기) 2026년 01월 01일∼2026년 03월 31일” (Korean for Quarterly Report) filed with the Financial Services Commission and Korea Exchange. It contains detailed interim financial data, business overview, capital changes, share counts, and subsidiary information for the quarter ending 31 March 2026. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(약식)
Regulatory Filings
2026-05-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean “주식등의 대량보유상황보고서” (Large Shareholding Report) detailing share ownership by a major shareholder and related parties, including dates, percentages, contract details and changes in holdings. This corresponds to a notification of significant shareholding levels (crossing thresholds). It is not an earnings release, capital change, or management announcement but a major shareholding disclosure filing. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2026-04-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a Korean “주식등의 대량보유상황보고서 (일반)” – a large‐shareholding report filed under the Capital Markets Act, disclosing major shareholders’ holdings, changes in share counts and percentages, share pledge and related contract information. It is not an earnings release or annual report, but a notification of significant shareholding changes. This matches the Major Shareholding Notification category.
2026-03-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.